Cellebrite DI (CLBT) vs Vertex (VERX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Vertex (VERX) has outperformed Cellebrite DI (CLBT) over the past year, losing 12.9% versus a loss of 36.2%. Over five years, CLBT leads with a +24.1% price change compared with -7.1% for VERX. Vertex is the larger company by market cap ($2.80 billion vs $2.71 billion), about 1.0 times the size, while Cellebrite DI is growing revenue faster (+18.6% vs +12.2%).
On valuation, Cellebrite DI trades at a lower forward P/E (16.1x vs 16.6x for Vertex). Cellebrite DI converts more of its revenue into profit, with a net margin of 16.5% versus 1.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLBT | VERX |
|---|---|---|
| Share price | $10.77 | $17.23 |
| Market cap | $2.71B | $2.80B |
| 1-day change | -4.86% | +0.29% |
| YTD return | -40.27% | -13.72% |
| 1-year return | -36.20% | -12.94% |
| 5-year return | +24.08% | -7.07% |
| P/E ratio (TTM) | 43.08 | — |
| Forward P/E | 16.09 | 16.58 |
| EPS (TTM) | $0.25 | $-0.30 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $475.68M | $748.44M |
| Revenue growth (YoY) | +18.56% | +12.25% |
| Net income (latest FY) | $78.33M | $7.21M |
| Gross margin | 84.20% | 64.35% |
| Operating margin | 13.98% | 0.31% |
| Net margin | 16.47% | 0.96% |
| 52-week high | $19.39 | $20.82 |
| 52-week low | $9.58 | $10.21 |
| Distance from 52-week high | -44.46% | -17.24% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +43.27% | +21.01% |
| Average volume | 2.35M | 1.45M |
| Shares outstanding | 251.34M | 80.11M |
| Employees | 1,285 | 2,000 |
| Sector | Technology | Technology |
| Industry | Computer Software: Prepackaged Software | Computer Software: Prepackaged Software |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- VERX has outperformed CLBT by 23.3 percentage points over the past year.
- Cellebrite DI is more profitable, keeping 16.5 cents of every revenue dollar as net income versus 1.0 cents for Vertex.
- Cellebrite DI grew revenue faster in its latest fiscal year (+18.56% vs +12.25%).
About Cellebrite DI
CLBT stock →Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
Technology · Computer Software: Prepackaged Software · 1,285 employees
About Vertex
VERX stock →Vertex, Inc., together with its subsidiaries, provides enterprise tax technology solutions for retail trade, wholesale trade, and manufacturing industries in the United States and internationally. The company offers transaction determination; compliance and reporting, including workflow management tools; tax data management and document management solutions; analytics and insights; pre-built integration that includes mapping data fields, and business logic and configurations; industry-specific solutions support certain industries for indirect tax needs, such as retail, communications, and leasing; and technology specific solutions, such as chain flow accelerator and SAP-specific tools.
Technology · Computer Software: Prepackaged Software · 2,000 employees
CLBT vs VERX FAQ
Which is bigger, Cellebrite DI or Vertex?
Vertex (VERX) is larger, with a market capitalization of $2.80B compared with $2.71B for Cellebrite DI (CLBT).
Which stock has performed better over the past year, CLBT or VERX?
VERX returned -12.94% over the past 12 months, compared with -36.20% for CLBT (price return, excluding dividends). Past performance does not predict future results.
Are Cellebrite DI and Vertex in the same industry?
Yes. Both are classified in the Computer Software: Prepackaged Software industry within the Technology sector.